Previous 10 | Next 10 |
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has been awarded a group purchasing agreement for SURPASS with Premier. Effective January 1, 2019, the new agreement offers Teleflex’s broad range of respiratory disposa...
Minimally Invasive UroLift System Treatment Provides Rapid Symptom Relief and Improved Quality of Life, While Preserving Sexual Function* 1,2 Teleflex Incorporated (NYSE:TFX) today announced that 100,000 patients have been treated globally with its minimally invasive UroLift ®...
Insys Therapeutics ( INSY ) has had an agonizing past two years due to the combination of financial and legal troubles. Federal investigations into the company and former executives have hurt sales, which in turn, has decimated the share price. However, the sales of its flagship commercial p...
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 40 th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida on Tuesday, March 5, 2019 at 4:00 p.m. (ET). A live audio webcast of the confe...
Favorable Coverage Decisions Broaden Access to This Minimally Invasive Treatment That Provides Rapid Relief and Recovery from Symptoms NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced tha...
NEW YORK, Feb. 08, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teleflex Incorporated (NYSE:TFX), Louisiana-Pacific Corporation (NYSE:...
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, February 21, 2019 Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2018 will be released before market open on Thursday, February 21, 2019. An investor conference call...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that it received premarket approval (PMA) from the U.S. Food and Drug Administration for the MANTA™ Vascular Closure Device – the first commercially...
Noteworthy events during the week of January 20 - 26 for healthcare investors. More news on: Lipocine Inc., Cue Biopharma, Johnson & Johnson, Healthcare stocks news, , Read more ...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies with solutions in the fields of vascular and interventional access, surgical and cardiac care, will showcase the MANTA™ Vascular Closure Device as well as its portfolio for peripheral interventions at...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Ringer™ Perfusion Balloon Catheter (PBC), the only commercially available Perc...
WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS® ...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...